The FDA proposed collaboration with the CMS to evaluate medical products to accelerate reimbursement decisions. The agencies would initiate a pilot project for medical devices after evaluating feedback on the proposal.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||